Skip to Content
  • 6.2
    Impact Factor
  • 12.1
    CiteScore
  • 18 days
    Submission to First Decision
  • 3 days
    Acceptance to Publication

Biosensors

Biosensors is an international, peer-reviewed, open access journal on the technology and science of biosensors, published monthly online by MDPI.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (5,655)

  • Article
  • Open Access

Background: Hemoglobin (Hb) is a key perioperative indicator of oxygen transport and tissue oxygenation. Intraoperative Hb measurement currently relies mainly on arterial blood gas analysis or laboratory testing, both of which are accurate but invasive and intermittent. This study evaluated the preliminary performance of a self-developed multi-wavelength photoplethysmography (PPG)-based non-invasive Hb detection system and assessed the effect of individualized calibration. Methods: This prospective observational study included 61 adults undergoing elective non-cardiac surgery with invasive arterial monitoring. Intraoperative multi-wavelength PPG signals and arterial blood gas Hb values were collected simultaneously. PPG-derived features were used to develop machine-learning models for Hb estimation. Model performance was evaluated using Pearson correlation, Bland–Altman analysis, and the proportions of predictions with absolute errors ≤ 1.0 g/dL and ≤1.5 g/dL. Performance before and after individualized calibration was compared. Results: A total of 200 paired Hb–PPG observations were obtained. Before calibration, the bias between predicted and reference Hb was 0.006 g/dL, with 95% limits of agreement (LoA) from −2.869 to +2.880 g/dL, and the correlation was moderate (r = 0.661). Absolute errors ≤ 1.0 g/dL and ≤1.5 g/dL were observed in 49.22% and 66.84% of predictions, respectively. After calibration using each patient’s first quality-controlled Hb measurement as individualized prior information, the bias was −0.006 g/dL, the 95% LoA narrowed to −1.834 to +1.822 g/dL, and the correlation increased to 0.870. The proportions of predictions with absolute errors ≤ 1.0 g/dL and ≤1.5 g/dL increased to 70.68% and 90.23%, respectively. Conclusions: The proposed multi-wavelength PPG-based system showed preliminary feasibility for non-invasive intraoperative Hb estimation. Individualized calibration further improved prediction accuracy and agreement, indicating the importance of patient-specific baseline information. At this stage, the system should be regarded as an adjunctive monitoring tool rather than a replacement for arterial blood gas analysis or laboratory Hb testing.

Biosensors

22 November 2026

Distribution of Hb measurement records by sex and Hb interval.
  • Article
  • Open Access

Rapid and dynamic assessment of antibacterial activity is important for optimizing antimicrobial treatment and evaluating new antibacterial agents. Whole-cell bioluminescent biosensors enable direct monitoring of bacterial responses, but their use in antibacterial drug evaluation remains limited. Here, we developed AlSma, a marker-free autoluminescent Stenotrophomonas maltophilia whole-cell biosensor, through one-step electroporation of the luxCDABE cassette and subsequent selectable-marker excision using a host-specific difS sequence identified by BLAST analysis and the endogenous Xer recombination system. AlSma exhibited stable, substrate-independent bioluminescence while retaining growth characteristics and antimicrobial susceptibility comparable to those of the parental strain. Relative light units (RLU) correlated strongly with viable bacterial counts in vitro. RLU-based assessment of ten antibacterial agents yielded susceptibility results consistent with those obtained by conventional broth microdilution in both CAMHB and LB and enabled dynamic monitoring of antibacterial activity. In a murine intraperitoneal infection model, longitudinal whole-animal RLU measurements enabled noninvasive monitoring of infection progression and treatment efficacy, with the observed treatment responses further supported by ex vivo tissue RLU measurements and conventional colony-forming unit (CFU) enumeration. AlSma represents a marker-free whole-cell biosensing platform integrating rapid in vitro antibacterial assessment with noninvasive in vivo therapeutic monitoring, with potential application in the preclinical evaluation of antibacterial agents.

Biosensors

22 November 2026

Construction and verification of marker-free AlSma. (A) Schematic representation of the construction of AlSma by chromosomal integration of the autoluminescence cassette followed by Xer/difS-mediated excision of the Gm resistance marker. Dashed arrows indicate the homologous recombination events occurring between the Up and Down homology arms. Ori, E. coli origin of replication; Target locus, chromosomal integration site in Sma (genomic position 1,295,300–1,295,320 bp), located in a non-essential non-coding region; Up/Down, approximately 1000-bp upstream and downstream homology arms flanking the target locus, corresponding to regions containing Sma06120 and Sma06125, respectively; Sma06115/Sma06130, genes flanking the homology arms and used for genomic positioning; Phelp, constitutive promoter; luxCDABE, bacterial bioluminescence operon; difS, sequence recognized by the XerC/XerD recombination system; PGmR, GmR promoter; GmR, gentamicin resistance gene. The above sequences are provided in the Supplementary Material. (B) PCR verification of AlSma::GmR. M, D5000 DNA marker; lanes 1–2, P1-F/P2-R amplicons using genomic DNA from WtSma (lane 1) and AlSma::GmR (lane 2) as templates; lanes 3–4, P3-F/P4-R amplicons using genomic DNA from Sma (lane 3) and AlSma::GmR (lane 4) as templates. (C) PCR verification of AlSma. M, D5000 DNA marker; lanes 1–3, P3-F/P4-R amplicons using genomic DNA from Sma (lane 1), AlSma::GmR (lane 2), and AlSma (lane 3) as templates. (D) Representative images of AlSma under normal illumination and in darkness.
  • Article
  • Open Access

Biliary stent dysfunction in malignant biliary obstruction remains clinically occult until jaundice or cholangitis develops because current surveillance methods yield no continuous functional information. This study presents a percutaneous transhepatic biliary drainage (PTBD)-based smart biliary stent incorporating a thin-film pressure sensor and evaluates its in vivo feasibility for continuous intrabiliary pressure monitoring. A resistive pressure sensor was fabricated on a liquid-crystal polymer substrate with gold-mesh electrodes encapsulated for bile exposure and integrated into a covered self-expandable metal stent. Following in vitro characterization under bile flow conditions, the device was evaluated in a porcine biliary stricture model created using endoscopic radiofrequency ablation. The sensor lead wire was externalized through a mature PTBD tract. The sensor exhibits a pressure-dependent resistance response and maintains electrical continuity after stent compression and expansion. Of the three animals, one completed the full workflow, from stricture formation to lead-wire externalization, allowing stable continuous pressure recording for approximately 48 h; the in vivo evaluation was therefore based on a single animal. After endoscopic hemoclip-induced distal stent occlusion, the intrabiliary pressure increased from approximately 200 Pa to approximately 3800 Pa within approximately 25 min. These findings provide preliminary evidence for the technical feasibility of PTBD-based smart biliary stent monitoring and suggest that intrabiliary pressure may serve as a real-time physiological indicator of stent dysfunction.

Biosensors

21 November 2026

Schematic of the smart biliary stent system for continuous intraductal pressure monitoring. A pressure sensor integrated into a covered self-expandable metal stent is deployed in the bile duct. The sensor lead wire is externalized through the percutaneous transhepatic biliary drainage (PTBD) tract and connected to an external recording unit that continuously acquires intraductal pressure waveforms. Pressure data are transmitted wirelessly via a network to a cloud server for real-time, continuous data storage and review.
  • Article
  • Open Access

The increasing prevalence of antimicrobial-resistant bacterial infections necessitates multifunctional biomaterials capable of integrating diagnosis with therapeutic intervention. Herein, we engineer an aptamer-functionalized AuNS@PDA core-shell nanoplatform for fluorescence detection and photothermal antibacterial treatment of Staphylococcus aureus. The rationally designed core–shell architecture enables the polydopamine shell to simultaneously serve as a fluorescence quencher and an aptamer immobilization interface, whereas the gold nanostar core and PDA shell together provide a pronounced near-infrared photothermal heating response. Target-associated fluorescence activation enabled bacterial imaging and concentration-dependent detection, with a calibration-derived detection threshold of approximately 285 CFU/mL. Under near-infrared irradiation, the AuNS@PDA core–shell structure generates photothermal heating, leading to membrane disruption and effective antibacterial activity. The nanoplatform thus combines fluorescence-based bacterial recognition with NIR-induced photothermal antibacterial activity under the tested in vitro conditions. By integrating aptamer-mediated bacterial recognition, fluorescence signal activation, and NIR-responsive photothermal antibacterial activity within a single platform, the proposed nanoplatform enables selective fluorescence detection and effective photothermal suppression of S. aureus under in vitro conditions. This core-shell design provides a promising strategy for developing multifunctional nanomaterials that combine bacterial sensing with photothermal antibacterial applications.

Biosensors

20 November 2026

Schematic illustration of the fabrication of the AuNS@PDA/Apt-FAM nanoprobe. (A) The fluorescence quenching/recovery process and photothermal conversion of the AuNS@PDA/Apt-FAM. (B) Schematic illustration of aptamer-associated fluorescence detection and AuNS@PDA-mediated photothermal treatment of Staphylococcus aureus.

Featured Articles of Last Quarter

A diagram showing the process flow (i) and major applications (ii–iv) of droplet acoustofluidics: (ii) active droplet generation; (iii) droplet sorting; (iv) in-droplet particle manipulation.
Wrist-worn cardiac impedance sensor. (a) Manufacturing process. (b) Position on the wrist. (c) Interaction of the electric field with the radial artery.

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Biosensors - ISSN 2079-6374